2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
6
Completed
6
Active not recruiting
3
Unknown
2
Withdrawn
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Papillomavirus Infections
2
Spondylarthritis
1
Interventions
Cisplatin
517
Radiotherapy
378
Cyclophosphamide
368
Carboplatin
359
Capecitabine
342
Paclitaxel
337
Oxaliplatin
336
Gemcitabine
322
Docetaxel
317
Fluorouracil
291
Drug Therapy
277
Bevacizumab
249
apatinib
247
camrelizumab
219
Etoposide
201
Irinotecan
183
Doxorubicin
181
Leucovorin
164
Dexamethasone
161
pembrolizumab
155
Neoadjuvant Therapy
146
sintilimab
145
anlotinib
140
Blood Specimen Collection
140
Pemetrexed
138
Cytarabine
138
toripalimab
133
Surgical Procedures, Operative
131
Radiosurgery
131
S 1 (combination)
125
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Human Papillomavirus DNA Tests
×
Clear all
NCT04794660
2024-03-13
CESTA
International Agency for Research on Cancer
Phase 3
Unknown
1,500 enrolled
NCT03713736
2021-07-27
PAPLOR
Hospices Civils de Lyon
Phase NA
Unknown
385 enrolled